DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20162859

Comparison of mathematical indices of insulin resistance for clinical application in the four phenotypes of polycystic ovarian syndrome

Amita Ray, Arun G., Sujaya V. Rao

Abstract


Background: Insulin resistance may not be essential for the diagnosis, but does play a crucial role in PCOS and contributes to significant morbidity and long term life threatening sequelae. The extent of this resistance differs in different phenotypes and is difficult to assess in clinical settings. In this study we used mathematical indices to assess insulin resistance across the whole PCOS spectrum and used cut off values to find whether all PCOS phenotypes were Insulin resistant.

Methods: 60 newly diagnosed PCOS participants were included in the study analysis. Depending upon their presentation these participants were grouped into 4 phenotypes. The two mathematical indices HOMA and QUICKI were calculated for each participant .The mean value of HOMA and QUICKI were calculated for each group and compared using ANOVA. A cut off value of >2.6 for HOMA and <0.33 for QUICKI was used to determine Insulin resistance.

Results: There was a significant difference in the degree of insulin resistance among the different phenotypes of PCOS. Not all PCOS women can be called insulin resistant when using certain cut off values for QUICKI and HOMA. The PCOM+MI+HA phenotype appears to be more resistant than all other phenotypes.

Conclusions: Insulin resistance is a not present universally and varies among all phenotypes of PCOS. In clinical setting simple mathematical indices could be used to identify these individuals and initiate appropriate therapy in order to prevent long term metabolic sequelae. Cut off values for both the indices need to take into account all factors that influence insulin sensitivity.

Keywords


PCOS, Phenotypes, Insulin resistance, Mathematical indices

Full Text:

PDF

References


Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu AM, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod. 2006;21(12):3108-15.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar- Morreale HF, Futterweit W, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-88.

Fauser CJM, Tarlatzis BC, Rebar RW. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group,” Fertility and Sterility. 2012;97(1):25-38.

Rojas J, Chávez M, Olivar L, Rojas M, Morillo J, Mejías J, Calvo M, Bermúdez V. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Intern J Reprod Med. 2014;2014:1-17.

Toprak S, Yonem A, Cakir B. Insulin resistance in non-obese patients with polycystic ovary syndrome. Hormone Res. 2001;55(2):65-70.

Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertility and Sterility. 2004;82(3):661-5.

Diamanti-Kandarakis E , Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews. 2012;33(6):981-1030.

Pauli JM, Raja-Khan N, Wu X, Legro RS. Current perspectives of insulin resistance and polycystic ovary syndrome. Diabetic Med. 2011;28(12):1445-54.

Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale AF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS). Society J Clin Endocrinol Metab. 2010:95(5):2038-49.

Traub ML. Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes. 2011;2(3):33-40.

Mantzoros CS, Flier JS. Insulin resistance: the clinical spectrum. In: Mazzaferi E, ed. Advances in endocrinology and metabolism. St. Louis: Mosby-Year Book; 1995;6:193-232.

Vidal-Puig A, Moller DE. Insulin resistance: Classification, prevalence, clinical manifestations, and diagnosis. In: Azziz R, Nestler JE Dewailly D, eds. Androgen excess disorders in women. Philadelphia: Lippincott Raven;1977:227-236.

Bergman RN. Towards physiological understanding of glucose tolerance: minimal model approach Diabetes. 1989;38:1512-7.

Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790-800.

Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. The J Clin Endocrinol Metabol. 2000;85(7):2402-10.

Hisayo Y, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care. 2003;26:2426-32.

Bhattacharya SM. Mathematical indices of insulin resistance and body mass index in polycystic ovarian syndrome J Obstet Gynecol India. 2005;55(2):159-62.

Ek I, Arner P, Rydén M. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 2002;51:484-92.

Rincon J, Holmäng A, Wahlström EO. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes. 1996;45:615-121.

Zang H, Carlström K, Arner P, Hirschberg AL. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women. Fertil Steril. 2006;86:136-44.

Zang H, Rydén M, Wåhlen K, Dahlman-Wrigth K, Arner P, Hirschberg AL. Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women. Fertil Steril. 2007;88:100-6.

Hettihawa LM, Palangasinghe S, Jayasinghe SS, Gunasekara SW, Weerarathna TP. Comparison of insulin resistance by indirect methods-HOMA, QUICKI and McAuley-with fasting insulin in patients with type 2 diabetes in Galle, Sri Lanka: A pilot study. Online J Health Allied Scs. 2006;1:2-6.

Lee S, Choi S, Kim H J, Chung Y C, Lee K W, Lee H C, Huh K B, et al. Cut off values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci. 2006;21:695-700.

Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study BMC. Endocrine Disorders. 2013;13:47.